Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine for Language-based Learning Skills in ADHD
NCT01146002Phase 4Completed
- Sponsor
- Neurology Group of Bergen County
- Start
- Jun 2010
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of guanfacine in attention deficit hyperactivity disorder (ADHD), sponsored by Neurology Group of Bergen County. Started Jun 2010; status: completed.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01146002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01146002.